Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Indemakitug by Elixiron Immunotherapeutics for Vitiligo: Likelihood of Approval
Indemakitug is under clinical development by Elixiron Immunotherapeutics and currently in Phase I for Vitiligo. According to GlobalData, Phase I...